SS

Sunil Shukla

Active Director Director DIN 09340032
DIN 09340032 First appointment Sep 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Sunil Shukla

Data last updated:

Sunil Shukla is a Director at Nektap Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Nektap Pharmaceuticals Private Limited reported revenue of ₹2.5 Lakh (FY 2024).

DIN 09340032
Primary Designation Director
Industry Trading
First Appointment 01 Sep 2021
Oldest Company Age 8 yrs
Largest company Nektap Pharmaceuticals Private Limited · ₹2.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20212017₹2.5 Lakh (FY 2024)Active

Board colleagues of Sunil Shukla

Directorship timeline

Open interactive timeline →
Nektap Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sunil Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Shukla

Sunil Shukla currently holds 1 directorship: Nektap Pharmaceuticals Private Limited (Director, since 01 Sep 2021, revenue ₹2.5 Lakh (FY 2024)).

Sunil Shukla was first appointed on 01 Sep 2021 as Director at Nektap Pharmaceuticals Private Limited.

The current boards of Sunil Shukla's companies include Aliya Rizvi (Nektap Pharmaceuticals Private Limited), Monika Saini (Nektap Pharmaceuticals Private Limited), Vishal Sahai (Nektap Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available